The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Current prospects of type II interferon γ signaling and autoimmunity
Open accessAbstract
Interferon γ (IFNγ) is a pleiotropic protein secreted by immune cells. IFNγ signals through the IFNγ receptor, a protein complex that mediates downstream signaling events. Studies into IFNγ signaling have provided insight into the general concepts of receptor signaling, receptor internalization, regulation of distinct signaling pathways, and transcriptional regulation. Although IFNγ is the central mediator of the adaptive immune response to pathogens, it has been shown to be involved in several non-infectious physiological processes. This review will provide an introduction into IFNγ signaling biology and the functional roles of IFNγ in the autoimmune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Macrophage plasticity and polarization: in vivo veritas
Sica, A., & Mantovani, A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59643 · Cited by 6,335 · cited 1×
“IFN activates macrophages toward the “M1” phenotype, which is characterized by the expression of high levels of pro-inflammatory cytokines such as Il-1 , IL-12, IL-23, and TNF- ; high production of reactive nitrogen and oxygen intermediates; promotion of Th1 T cell response; and strong inflammatory activity (6).”
BackgroundHu, X., & Ivashkiv, L. B. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.002 · Cited by 928
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
Johnson, D. B., Sullivan, R. J., Ott, P. A., Carlino, M. S., Khushalani, N. I., Ye, F., Guminski, A., Puzanov, I., Lawrence, D. P., Buchbinder, E. I., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.4368 · Cited by 642 · cited 1×
“In a small cohort of AD patients that develop melanoma, CTLA4 blockade induces tumor growth inhibition, but 25–50% developed mild to moderate exacerbations of their AD or experienced conventional CTLA4-induced irAEs, respectively (10).”
BackgroundGAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression
DECKER, T., KOVARIK, P., & MEINKE, A. (1997) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1997.17.121 · Cited by 437
Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., Mietton, F., Matteoli, G., Hiebert, S., & Natoli, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121131109 · Cited by 397 · cited 1×
“In turn, histone deacetylase 3 (HDAC3) deacetylates STAT1, thus permitting a new cycle of phosphorylation and re-stimulation (13).”
BackgroundVIALLARD, J. F., PELLEGRIN, J. L., RANCHIN, V, SCHAEVERBEKE, T., DEHAIS, J., LONGY-BOURSIER, M., RAGNAUD, J. M., LENG, B., & MOREAU, J. F. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00766.x · Cited by 247
Interferons and the immunogenic effects of cancer therapy
Minn, A. J. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.09.007 · Cited by 130
IFNγR2 trafficking tunes IFNγ–STAT1 signaling in T lymphocytes
Regis, G., Conti, L., Boselli, D., & Novelli, F. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.12.002 · Cited by 48
Cited by
Interferon-γ: teammate or opponent in the tumour microenvironment?
Gocher, A. M., Workman, C. J., & Vignali, D. A. A. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00566-3 · Cited by 582
Wolska, A., Dunbar, R. L., Freeman, L. A., Ueda, M., Amar, M. J., Sviridov, D. O., & Remaley, A. T. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.10.025 · Cited by 231
The immunobiology of female predominance in primary biliary cholangitis
Gerussi, A., Cristoferi, L., Carbone, M., Asselta, R., & Invernizzi, P. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.10.015 · Cited by 41
Relationships of Non-coding RNA with diabetes and depression
An, T., Zhang, J., Ma, Y., Lian, J., Wu, Y.-X., Lv, B.-H., Ma, M.-H., Meng, J.-H., Zhou, Y.-T., Zhang, Z.-Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47077-9 · Cited by 27
Metadata
- Authors
- Green, D. S., Young, H. A., & Valencia, J. C.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 292
- Issue
- 34
- Pages
- 13925-13933
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2731035140
- Cited by
- 172
- References
- 8
- FWCI
- 7.22
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Current prospects of type II interferon γ signaling and autoimmunity. https://app.cochat.ai/papers/10.1074/jbc.r116.774745
- The paper
- Green, D. S., Young, H. A., & Valencia, J. C. (2017). Current prospects of type II interferon γ signaling and autoimmunity. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.r116.774745
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.